Literature DB >> 14259336

TREATMENT OF CONGESTIVE HEART FAILURE WITH TRIAMTERENE.

J WENER, R SCHUCHER, R FRIEDMAN.   

Abstract

Triamterene, a newer oral diuretic, was administered to nine hospitalized patients with congestive heart failure for an average of 15 days, and to 22 ambulatory patients for a period of three to 11 months. The daily dosage of triamterene ranged from 50 to 250 mg., but usually 100-200 mg. was administered daily in two divided doses, with or without the addition of 50 mg. of hydrochlorothiazide daily.Triamterene is a safe and effective diuretic at doses of 100-200 mg. daily and no drug tolerance develops with long-term therapy. However, when used alone, it is not as effective as hydrochlorothiazide, but in combination with the latter drug the resultant diuresis is unsurpassed by any other oral diuretic therapy that we have used to date.Triamterene itself does not produce kaliuresis and it blocks thiazide-induced kaliuresis. Serum uric acid levels may rise slightly, but no clinical gout was seen in this study.

Entities:  

Keywords:  BLOOD; DIURESIS; DRUG THERAPY; GOUT; HEART FAILURE, CONGESTIVE; HYDROCHLOROTHIAZIDE; POTASSIUM; TOXICOLOGIC REPORT; TRIAMTERENE; URIC ACID; WATER-ELECTROLYTE BALANCE

Mesh:

Substances:

Year:  1965        PMID: 14259336      PMCID: PMC1927822     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  12 in total

1.  Diuretic action of triamterene in man.

Authors:  W R CATTELL; C W HAVARD
Journal:  Br Med J       Date:  1962-11-24

2.  Triamterene, a new diuretic drug. I. Studies in normal men and in adrenalectomized rats.

Authors:  W I BABA; G R TUDHOPE; G M WILSON
Journal:  Br Med J       Date:  1962-09-22

3.  Triamterene, a new natruretic agent. Preliminary observations in man.

Authors:  A P CROSLEY; L M RONQUILLO; W H STRICKLAND; F ALEXANDER
Journal:  Ann Intern Med       Date:  1962-02       Impact factor: 25.391

4.  Clinical trial of new oral diuretic-SKF 8542.

Authors:  R J DONNELLY; P TURNER; G S SOWRY
Journal:  Lancet       Date:  1962-02-03       Impact factor: 79.321

5.  [2,4,7-Triamino-6-phenylpteridine as an "aldosterone antagonist"].

Authors:  H HERKEN; G SENFT
Journal:  Klin Wochenschr       Date:  1961-12-01

6.  [Research on the effect of 2,4,7-triamino-6-phenylpteridine in man].

Authors:  F KRUECK; R HILD
Journal:  Klin Wochenschr       Date:  1961-12-15

7.  A modified carbonate-phosphotungstate method for the determination of uric acid and comparison with the spectrophotometric uricase method.

Authors:  R J HENRY; C SOBEL; J KIM
Journal:  Am J Clin Pathol       Date:  1957-08       Impact factor: 2.493

8.  An automatic method for colorimetric analysis.

Authors:  L T SKEGGS
Journal:  Am J Clin Pathol       Date:  1957-09       Impact factor: 2.493

9.  Chlorothiazide in the management of cardiac oedema.

Authors:  J WENER; R FRIEDMAN; R SCHUCHER
Journal:  Can Med Assoc J       Date:  1958-04-15       Impact factor: 8.262

10.  Determination of urea nitrogen with the diacetyl method and an automatic dialyzing apparatus.

Authors:  W H MARSH; B FINGERHUT; E KIRSCH
Journal:  Am J Clin Pathol       Date:  1957-12       Impact factor: 2.493

View more
  2 in total

1.  A study in human pharmacology: evaluation of four diuretics and a placebo.

Authors:  L Joubert; C Radouco-Thomas; J M Loiselle; S Radouco-Thomas; L Turmel-Dorion; Y Warren
Journal:  Can Med Assoc J       Date:  1968-07-13       Impact factor: 8.262

2.  Potassium-sparing agents during diuretic therapy in hypertension.

Authors:  T J McKenna; J F Donohoe; T G Brien; J J Healy; B S Canning; F P Muldowney
Journal:  Br Med J       Date:  1971-06-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.